Cell Therapy Market Size, Trends, Growth and Report to 2022-27

The latest research study „Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“ by IMARC Group, finds that the global cell therapy market size reached US$ 9.17 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 27.05 Billion by 2027, exhibiting a growth rate (CAGR) of 18.60% during 2022-2027.

Cell therapy (CT) represents the transplantation of human cells to repair or replace damaged tissues and cells. It comprises skeletal muscle and mesenchymal stem cells, hematopoietic stem cells (HSC), lymphocytes, and dendritic and pancreatic islet cells. Cell therapy improves the immune system of the body to fight cancer cells. It also assists in treating various conditions, such as urinary problems, damaged cartilage in joints, spinal cord injuries, autoimmune and infectious diseases, a weakened immune system, neurological disorders, etc. As a result, cell therapy finds extensive utilization in manufacturing regenerative medicines for developing and applying new treatments to heal tissues and organs and restoring functions lost, owing to disease, aging, and damage.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/cell-therapy-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Cell Therapy Market Trends and Drivers:

The escalating prevalence of several diseases, including cancer and cardiac abnormalities, across the globe and the growing number of clinical studies for cell-based treatments are among the primary factors driving the cell therapy market. Besides this, the introduction of skin rejuvenation and tendon regeneration cures and the development of direct cell reprogramming to replace lost neuronal tissues, on account of neurodegeneration or neurotrauma, are further augmenting the market growth.

Moreover, the launch of advanced genomic therapy techniques to treat various conditions, such as heart disease, diabetes, hemophilia, cystic fibrosis, and acquired immune deficiency syndrome (AIDS), and the expanding healthcare industry are also catalyzing the global market. Apart from this, the elevating demand for regenerative medicines to replace organs damaged by illnesses, traumas, or congenital issues is anticipated to propel the cell therapy market over the forecasted period.

Report Coverage:

Cell Therapy Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

AlloSource, Anterogen Co. Ltd., Cells for Cells, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, Kolon TissueGene Inc., MEDIPOST, Mesoblast Limited, NuVasive, Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd and Vericel Corporation.

The report has segmented the market on the basis of cell type, therapy type, therapeutic area and end user.

Cell Type:

• Stem Cell
  • Bone Marrow
  • Blood
  • Umbilical Cord-Derived
  • Adipose-Derived Stem Cell
  • Others
• Non-stem Cell

Therapy Type:

• Autologous
• Allogeneic

Therapeutic Area:

• Malignancies
• Musculoskeletal Disorders
• Autoimmune Disorders
• Dermatology
• Others

End User:

• Hospitals and Clinics
• Academic and Research Institutes

Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

1    Preface
2    Scope and Methodology
2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
4.1    Overview
4.2    Key Industry Trends
5    Global Cell Therapy Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6    Market Breakup by Cell Type
6.1    Stem Cell
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Bone Marrow
6.1.2.2 Blood
6.1.2.3 Umbilical Cord-Derived
6.1.2.4 Adipose-Derived Stem Cell
6.1.2.5 Others
6.1.3 Market Forecast
6.2    Non-stem Cell
6.2.1 Market Trends
6.2.2 Market Forecast
7    Market Breakup by Therapy Type
7.1    Autologous
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Allogeneic
7.2.1 Market Trends
7.2.2 Market Forecast
8    Market Breakup by Therapeutic Area
8.1    Malignancies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Musculoskeletal Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3    Autoimmune Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4    Dermatology
8.4.1 Market Trends
8.4.2 Market Forecast
8.5    Others
8.5.1 Market Trends
8.5.2 Market Forecast
9    Market Breakup by End User
9.1    Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2    Academic and Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
10    Market Breakup by Region
10.1    North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2    Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3    Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4    Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5    Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11    SWOT Analysis
11.1    Overview
11.2    Strengths
11.3    Weaknesses
11.4    Opportunities
11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis
13.1    Overview
13.2    Bargaining Power of Buyers
13.3    Bargaining Power of Suppliers
13.4    Degree of Competition
13.5    Threat of New Entrants
13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape
15.1    Market Structure
15.2    Key Players
15.3    Profiles of Key Players
15.3.1    AlloSource
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.2    Anterogen Co. Ltd.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.3    Cells for Cells
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4    Holostem Terapie Avanzate S.r.l.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5    JCR Pharmaceuticals
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6    Kolon TissueGene Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7    MEDIPOST
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8    Mesoblast Limited
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9    NuVasive
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10    Stemedica Cell Technologies Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11    Stempeutics Research Pvt. Ltd
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12    Vericel Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Also Read; https://www.couponkaka.com/biogas-plant-market-size-global-share-growth-report-to-2022-27/